A review of 208 articles looked at how artificial intelligence (AI) performs when interpreting dermatoscopic images. These are specialized images used to look at skin conditions. The study compared AI performance against traditional methods where clinicians or experts look at the images alone or in combination with a physical exam.
The findings show that AI had high diagnostic performance for identifying melanoma and basal cell carcinoma. In some cases, AI showed higher sensitivity for melanoma than when doctors combined clinical exams with skin images. However, the results were not clear regarding whether AI was more sensitive than human experts for identifying squamous cell carcinoma or basal cell carcinoma when both were assessed together.
While the technology shows promise, it is still being evaluated. The study suggests that AI could help reduce the workload for healthcare providers and assist doctors in primary care settings. Because the evidence for certain skin cancers is not yet fully clear, these tools are currently seen as a way to support, rather than replace, clinical judgment.